Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
1 Apr 24
424B3
Prospectus supplement
26 Mar 24
8-K
Rennova Health, Inc., Announces the Expiration of Warrants to Purchare Over Four Hundred Billion Common Shares
26 Mar 24
424B3
Prospectus supplement
10 Jan 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Rennova Health, Inc. Announces Significant Debt Restructuring
31 Oct 23
8-K
Rennova Health, Inc. Provides Update after Filing 2023 Second Quarter Financial Statements
21 Aug 23
10-Q
2023 Q2
Quarterly report
15 Aug 23
NT 10-Q
Notice of late quarterly filing
14 Aug 23
424B3
Prospectus supplement
16 May 23
10-Q
2023 Q1
Quarterly report
15 May 23
EFFECT
Notice of effectiveness
12 May 23
CORRESP
Correspondence with SEC
11 May 23
S-1/A
IPO registration (amended)
9 May 23
8-K
Rennova Health, Inc. Provides Update after Filing 2022 Financial Statements
24 Apr 23
10-K
2022 FY
Annual report
17 Apr 23
NT 10-K
Notice of late annual filing
31 Mar 23
8-K
Rennova Health, Inc. Provides Update on 2022 Financials and Myrtle Recovery Centers
23 Feb 23
UPLOAD
Letter from SEC
4 Jan 23
S-1
IPO registration
30 Dec 22
8-K
Other Events
23 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Rennova Health, Inc. Provides Q3 2022 Performance Update
20 Oct 22
8-K
Other Events
23 Sep 22
8-K
Rennova Health, Inc. Provides Business Update
14 Sep 22
10-Q
2022 Q2
Quarterly report
15 Aug 22
8-K
Rennova Health, Inc. Discusses Progress and Plans for Mental and Behavioral Health Division with the Stock Day Podcast
16 Jun 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
8-K
Rennova Health, Inc. Discusses 2021 Financial Results and Company Progress with the Stock Day Podcast
27 Apr 22
10-K
2021 FY
Annual report
15 Apr 22
D/A
$1.5M in equity / options / securities to be acquired, sold $1.5M, 2 investors
7 Apr 22
8-K
Entry into a Material Definitive Agreement
7 Apr 22
NT 10-K
Notice of late annual filing
31 Mar 22
D
$1.5M in equity / options / securities to be acquired, sold $1M, 2 investors
17 Mar 22
8-K
Rennova Health, Inc. Completes Reverse Stock Split
16 Mar 22
8-K
Rennova Health, Inc. Announces Reverse Stock Split
10 Mar 22
8-K
Entry into a Material Definitive Agreement
1 Feb 22
8-K
Submission of Matters to a Vote of Security Holders
17 Dec 21
D/A
$4M in equity / options / securities to be acquired, sold $4M, 2 investors
17 Dec 21
Latest ownership filings
SC 13D/A
Diamantis Christopher Eric
30 Sep 21
4
Christopher Eric Diamantis
30 Sep 21
4
Christopher Eric Diamantis
27 Sep 21
SC 13D
Diamantis Christopher Eric
27 Sep 21
SC 13D/A
Lagan Seamus
14 Oct 20
SC 13D/A
Lagan Seamus
26 Aug 20
SC 13G/A
Rennova Health, Inc.
22 Jan 20
SC 13D/A
Rennova Health, Inc.
25 Oct 19
3
Jonathan Immordino
15 Apr 19
SC 13D/A
Rennova Health, Inc.
21 Aug 18
SC 13D/A
Rennova Health, Inc.
15 Aug 18
4
Seamus Lagan
25 Jul 18
3
Marlene McLennan
3 Jul 18
4
John Beach
14 May 18
4
Seamus Lagan
8 Mar 18
4
Christopher Eric Diamantis
8 Mar 18
4
Kamran Ajami
8 Mar 18
4
Trevor Langley
8 Mar 18
4
GARY L BLUM
8 Mar 18
SC 13D/A
NanoVibronix, Inc.
21 Feb 18
SC 13G/A
Rennova Health, Inc.
9 Jan 18
3
John Beach
20 Oct 17
3
GARY L BLUM
18 Oct 17
4
Trevor Langley
17 Aug 17
4
Christopher Eric Diamantis
17 Aug 17
4
Kamran Ajami
17 Aug 17
4
Seamus Lagan
17 Aug 17
SC 13G
Rennova Health, Inc.
11 Jul 17
3
MICHAEL H POLLACK
24 May 17
3
Trevor Langley
12 May 17
3
Kamran Ajami
2 May 17
4
Christopher Eric Diamantis
18 Apr 17
SC 13D/A
Rennova Health, Inc.
17 Feb 17
4
Steven Sramowicz
16 Feb 17
SC 13D/A
Rennova Health, Inc.
16 Feb 17
4
Steven Sramowicz
15 Feb 17
SC 13D/A
Rennova Health, Inc.
15 Feb 17
4
Steven Sramowicz
15 Feb 17
SC 13D/A
Rennova Health, Inc.
1 Feb 17
SC 13G/A
Rennova Health, Inc.
11 Jan 17